Breaking News Instant updates and real-time market news.

DOCU

DocuSign

$128.70 /

+1.46 (+1.15%)

07:21
05/21/20
05/21
07:21
05/21/20
07:21

DocuSign price target raised to $150 from $85 at RBC Capital

RBC Capital analyst Alex Zukin raised the firm's price target on DocuSign to $150 from $85 and keeps an Outperform rating on the shares ahead of its earnings next week. The analyst sees accelerating demand trends for the company due to COVID-19 outbreak, with upside to guidance and consensus estimates for Q1 results. Zukin adds that he sees a long-term runway for revenue growth with potential to remain elevated for longer in the mid 30% range.

  • 29

    May

  • 04

    Jun

  • 15

    Jun

DOCU DocuSign
$128.70 /

+1.46 (+1.15%)

05/21/20 Citi
DocuSign price target raised to $150 from $85 at Citi
04/20/20 Evercore ISI
DocuSign downgraded to In Line from Outperform at Evercore ISI
04/16/20 Wedbush
DocuSign price target raised to $115 from $90 at Wedbush
03/13/20 RBC Capital
DocuSign price target lowered to $85 from $93 at RBC Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Venrock reports 3M passive stake in Altimmune » 17:21
06/01/20
06/01
17:21
06/01/20
17:21
ALT

Altimmune

$8.63 /

-0.65 (-7.00%)

Venrock Healthcare…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$8.63 /

-0.65 (-7.00%)

ALT Altimmune
$8.63 /

-0.65 (-7.00%)

10:33 Today Roth Capital
Altimmune surprises with differentiated T-COVID study, says Roth Capital
05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
ALT Altimmune
$8.63 /

-0.65 (-7.00%)

ALT Altimmune
$8.63 /

-0.65 (-7.00%)

ALT Altimmune
$8.63 /

-0.65 (-7.00%)

Downgrade
Evolent Health downgraded to Neutral from Overweight at Cantor Fitzgerald » 17:13
06/01/20
06/01
17:13
06/01/20
17:13
EVH

Evolent Health

$6.84 /

-2.05 (-23.06%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

13:52 Today Piper Sandler
Evolent Health core business is undervalued, says Piper Sandler
07:13 Today Cantor Fitzgerald
Evolent Health price target lowered to $9 from $14 at Cantor Fitzgerald
06:53 Today Piper Sandler
Kentucky contract positive for Molina, negative for Anthem, says Piper Sandler
06:42 Today Stephens
Molina Healthcare price target raised to $215 from $202 at Stephens
EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

EVH Evolent Health
$6.84 /

-2.05 (-23.06%)

Hot Stocks
RH sees 'clear path to 20% operating margins over next few years' » 17:12
06/01/20
06/01
17:12
06/01/20
17:12
RH

RH

$212.54 /

-4.73 (-2.18%)

RH released a copy of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

04/29/20 Gordon Haskett
RH downgraded to Underperform following 80% run-up at Gordon Haskett
04/29/20 Gordon Haskett
RH downgraded to Underperform from Hold at Gordon Haskett
04/14/20 Barclays
RH price target raised to $154 from $120 at Barclays
04/01/20 Loop Capital
RH price target lowered to $110 from $210 at Loop Capital
RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

RH RH
$212.54 /

-4.73 (-2.18%)

Hot Stocks
Federal Realty provides COVID-19 update, sees all 104 properties remaining open » 17:10
06/01/20
06/01
17:10
06/01/20
17:10
FRT

Federal Realty

$84.94 /

+4.95 (+6.19%)

Federal Realty provided…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FRT Federal Realty
$84.94 /

+4.95 (+6.19%)

04/22/20 Wells Fargo
Federal Realty price target lowered to $85 from $149 at Wells Fargo
04/22/20 JPMorgan
JPMorgan downgrades seven, upgrades one strip center REIT
04/22/20 JPMorgan
Federal Realty downgraded to Neutral from Overweight at JPMorgan
04/20/20 Evercore ISI
Federal Realty downgraded to Underperform from In Line at Evercore ISI
FRT Federal Realty
$84.94 /

+4.95 (+6.19%)

Periodicals
Western Union makes offer to acquire MoneyGram, Bloomberg reports » 17:05
06/01/20
06/01
17:05
06/01/20
17:05
WU

Western Union

$20.75 /

+0.72 (+3.59%)

, MGI

MoneyGram

$2.60 /

+0.185 (+7.66%)

Western Union (WU) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WU Western Union
$20.75 /

+0.72 (+3.59%)

MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

WU Western Union
$20.75 /

+0.72 (+3.59%)

04/08/20 Wells Fargo
Western Union downgraded to Underweight from Equal Weight at Wells Fargo
04/06/20 Barclays
Western Union price target lowered to $18 from $25 at Barclays
04/03/20 Northcoast
Northcoast cuts estimates for MoneyGram and Western Union
04/02/20 SunTrust
Western Union price target lowered to $18 from $27 at SunTrust
MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

04/06/20 Barclays
MoneyGram price target lowered to $1 from $2 at Barclays
04/03/20 Northcoast
Northcoast cuts estimates for MoneyGram and Western Union
03/24/20 Northland
Northland downgrades MoneyGram to Market Perform on coronavirus lockdowns
03/24/20 Northland
MoneyGram downgraded to Market Perform from Outperform at Northland
WU Western Union
$20.75 /

+0.72 (+3.59%)

MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

WU Western Union
$20.75 /

+0.72 (+3.59%)

MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

WU Western Union
$20.75 /

+0.72 (+3.59%)

MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

Hot Stocks
InfuSystem director Gregg Lehman sold almost $460K in company shares » 17:04
06/01/20
06/01
17:04
06/01/20
17:04
INFU

InfuSystem

$11.75 /

+0.185 (+1.60%)

InfuSystem director Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INFU InfuSystem
$11.75 /

+0.185 (+1.60%)

Conference/Events
Aduro Biotech to hold a conference call » 17:04
06/01/20
06/01
17:04
06/01/20
17:04
ADRO

Aduro Biotech

$3.38 /

+0.1 (+3.05%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

01/10/20 Cowen
Aduro downgraded to Market Perform on limited visibility at Cowen
01/10/20 Cowen
Aduro Biotech downgraded to Market Perform from Outperform at Cowen
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/18/19 William Blair
Aduro Biotech downgraded to Market Perform from Outperform at William Blair
ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

ADRO Aduro Biotech
$3.38 /

+0.1 (+3.05%)

Hot Stocks
SL Green Realty provides update on collections, One Vanderbilt Avenue » 17:03
06/01/20
06/01
17:03
06/01/20
17:03
SLG

SL Green Realty

$44.03 /

+1.93 (+4.58%)

SL Green Realty has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLG SL Green Realty
$44.03 /

+1.93 (+4.58%)

SLG SL Green Realty
$44.03 /

+1.93 (+4.58%)

05/28/20 Morgan Stanley
Morgan Stanley downgrades Vornado, upgrades SL Green in NYC Office REIT shuffle
05/28/20 Morgan Stanley
SL Green Realty upgraded to Equal Weight from Underweight at Morgan Stanley
05/05/20 BMO Capital
SL Green Realty price target raised to $65 from $55 at BMO Capital
04/24/20 Piper Sandler
SL Green Realty downgraded to Neutral from Overweight at Piper Sandler
SLG SL Green Realty
$44.03 /

+1.93 (+4.58%)

SLG SL Green Realty
$44.03 /

+1.93 (+4.58%)

SLG SL Green Realty
$44.03 /

+1.93 (+4.58%)

Syndicate
Splunk files to sell $900M of convertible senior notes due 2027  17:01
06/01/20
06/01
17:01
06/01/20
17:01
SPLK

Splunk

$186.68 /

+0.69 (+0.37%)

 
ShowHide Related Items >><<
SPLK Splunk
$186.68 /

+0.69 (+0.37%)

SPLK Splunk
$186.68 /

+0.69 (+0.37%)

05/26/20 Argus
Splunk price target raised to $215 from $156 at Argus
05/22/20 JMP Securities
Splunk price target raised to $200 from $155 at JMP Securities
05/22/20 JPMorgan
Splunk price target raised to $190 from $174 at JPMorgan
05/22/20 Raymond James
Splunk price target raised to $185 from $140 at Raymond James
SPLK Splunk
$186.68 /

+0.69 (+0.37%)

SPLK Splunk
$186.68 /

+0.69 (+0.37%)

SPLK Splunk
$186.68 /

+0.69 (+0.37%)

Hot Stocks
Ligand working with Gilead to meet need for remdesivir » 16:58
06/01/20
06/01
16:58
06/01/20
16:58
LGND

Ligand

$102.28 /

+0.55 (+0.54%)

, GILD

Gilead

$75.15 /

-2.64 (-3.39%)

Ligand Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LGND Ligand
$102.28 /

+0.55 (+0.54%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

LGND Ligand
$102.28 /

+0.55 (+0.54%)

04/29/20 Craig-Hallum
Ligand has 'significant upside' if remdesivir is approved, says Craig-Hallum
04/08/20 H.C. Wainwright
Ligand price target lowered to $229 from $237 at H.C. Wainwright
04/06/20 H.C. Wainwright
H.C. Wainwright says Captisol a 'key focus' for Ligand, reiterates Buy
03/24/20 Argus
Ligand downgraded to Hold from Buy at Argus
GILD Gilead
$75.15 /

-2.64 (-3.39%)

10:25 Today Piper Sandler
Remdesivir now proven effective for COVID-19 in three studies, says Piper
05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
05/27/20 Wedbush
Arcus Biosciences price target raised to $48 from $40 at Wedbush
05/27/20 Piper Sandler
Piper says partnership more favorable for Gilead than outright Arcus purchase
LGND Ligand
$102.28 /

+0.55 (+0.54%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

LGND Ligand
$102.28 /

+0.55 (+0.54%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

Earnings
NGL Energy Partners reports Q4 EPS ($2.09), consensus 13c » 16:56
06/01/20
06/01
16:56
06/01/20
16:56
NGL

NGL Energy Partners

$5.77 /

+0.69 (+13.58%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NGL NGL Energy Partners
$5.77 /

+0.69 (+13.58%)

NGL NGL Energy Partners
$5.77 /

+0.69 (+13.58%)

04/02/20 Credit Suisse
NGL Energy Partners downgraded to Underperform from Neutral at Credit Suisse
03/16/20 RBC Capital
RBC Capital cuts select Energy names on leverage, counterparty concerns
03/16/20 RBC Capital
NGL Energy Partners downgraded to Sector Perform from Outperform at RBC Capital
03/12/20 Raymond James
NGL Energy Partners downgraded to Market Perform from Outperform at Raymond James
NGL NGL Energy Partners
$5.77 /

+0.69 (+13.58%)

NGL NGL Energy Partners
$5.77 /

+0.69 (+13.58%)

Conference/Events
HollyFrontier to hold a conference call » 16:55
06/01/20
06/01
16:55
06/01/20
16:55
HFC

HollyFrontier

$31.20 /

-0.27 (-0.86%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HFC HollyFrontier
$31.20 /

-0.27 (-0.86%)

HFC HollyFrontier
$31.20 /

-0.27 (-0.86%)

05/13/20 Morgan Stanley
U.S. gasoline consumption appears to have bottomed, says Morgan Stanley
05/04/20 Mizuho
Mizuho upgrades Valero, Phillips 66 and HollyFrontier to Buy from Neutral
05/04/20 Mizuho
HollyFrontier upgraded to Buy from Neutral at Mizuho
03/27/20 Wolfe Research
HollyFrontier upgraded to Outperform from Peer Perform at Wolfe Research
HFC HollyFrontier
$31.20 /

-0.27 (-0.86%)

HFC HollyFrontier
$31.20 /

-0.27 (-0.86%)

HFC HollyFrontier
$31.20 /

-0.27 (-0.86%)

Earnings
EnerSys reports Q4 EPS $1.11, consensus $1.18 » 16:54
06/01/20
06/01
16:54
06/01/20
16:54
ENS

EnerSys

$65.32 /

+1.9 (+3.00%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENS EnerSys
$65.32 /

+1.9 (+3.00%)

ENS EnerSys
$65.32 /

+1.9 (+3.00%)

04/02/20 Oppenheimer
EnerSys price target lowered to $75 from $80 at Oppenheimer
ENS EnerSys
$65.32 /

+1.9 (+3.00%)

ENS EnerSys
$65.32 /

+1.9 (+3.00%)

Hot Stocks
Era Group announces board approval to effect reverse stock split » 16:52
06/01/20
06/01
16:52
06/01/20
16:52
ERA

Era Group

$4.93 /

-0.095 (-1.89%)

Era Group announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ERA Era Group
$4.93 /

-0.095 (-1.89%)

ERA Era Group
$4.93 /

-0.095 (-1.89%)

03/09/20 Evercore ISI
Era Group downgraded to In Line from Outperform at Evercore ISI
ERA Era Group
$4.93 /

-0.095 (-1.89%)

Syndicate
Clarivate Analytics files to sell 14M ordinary shares, holders to offer 26M » 16:51
06/01/20
06/01
16:51
06/01/20
16:51
CCC

Clarivate Analytics

$24.12 /

+1.18 (+5.14%)

Clarivate announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCC Clarivate Analytics
$24.12 /

+1.18 (+5.14%)

CCC Clarivate Analytics
$24.12 /

+1.18 (+5.14%)

05/06/20 Citi
Clarivate Analytics price target raised to $28 from $24 at Citi
04/09/20 Goldman Sachs
Clarivate Analytics upgraded to Buy from Neutral at Goldman Sachs
04/03/20 Citi
Clarivate reinstated with a Buy from Neutral at Citi (yesterday)
04/02/20 Citi
Clarivate Analytics upgraded to Buy from Neutral at Citi
CCC Clarivate Analytics
$24.12 /

+1.18 (+5.14%)

Hot Stocks
Green Dot Chief Technology Officer Kuan Archer to step down » 16:49
06/01/20
06/01
16:49
06/01/20
16:49
GDOT

Green Dot

$38.23 /

-0.01 (-0.03%)

On June 1, 2020, Green…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDOT Green Dot
$38.23 /

-0.01 (-0.03%)

GDOT Green Dot
$38.23 /

-0.01 (-0.03%)

05/20/20 Northland
Green Dot price target raised to $42 from $35 at Northland
05/12/20 SunTrust
Green Dot price target raised to $50 from $40 at SunTrust
05/12/20 Craig-Hallum
Green Dot price target raised to $42 from $35 at Craig-Hallum
05/12/20 Needham
Green Dot price target raised to $40 from $30 at Needham
GDOT Green Dot
$38.23 /

-0.01 (-0.03%)

GDOT Green Dot
$38.23 /

-0.01 (-0.03%)

Conference/Events
Cantor pharmaceuticals analysts to hold an analyst/industry conference call » 16:48
06/01/20
06/01
16:48
06/01/20
16:48
RIGL

Rigel Pharmaceuticals

$1.94 /

-0.005 (-0.26%)

Pharmaceuticals Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RIGL Rigel Pharmaceuticals
$1.94 /

-0.005 (-0.26%)

RIGL Rigel Pharmaceuticals
$1.94 /

-0.005 (-0.26%)

02/27/20 Piper Sandler
Piper Sandler continues to like Rigel Pharmaceuticals setup
01/16/20 H.C. Wainwright
Rigel launch of Tavalisse remains encouraging, says H.C. Wainwright
01/13/20 Piper Sandler
Rigel still one of the most under-appreciated stories in sector, says Piper
11/15/19
Fly Intel: Top five analyst initiations
RIGL Rigel Pharmaceuticals
$1.94 /

-0.005 (-0.26%)

RIGL Rigel Pharmaceuticals
$1.94 /

-0.005 (-0.26%)

Syndicate
Cortexyme files automatic mixed securities shelf  16:47
06/01/20
06/01
16:47
06/01/20
16:47
CRTX

Cortexyme

$44.48 /

-1.99 (-4.28%)

 
ShowHide Related Items >><<
CRTX Cortexyme
$44.48 /

-1.99 (-4.28%)

CRTX Cortexyme
$44.48 /

-1.99 (-4.28%)

05/13/20 Canaccord
Cortexyme price target raised to $70 from $42 at Canaccord
06/03/19
Fly Intel: Top five analyst initiations
06/03/19 Credit Suisse
Cortexyme initiated with an Underperform at Credit Suisse
06/03/19 Canaccord
Cortexyme initiated with a Buy at Canaccord
CRTX Cortexyme
$44.48 /

-1.99 (-4.28%)

Initiation
Pros Holdings initiated with an Outperform at Baird » 16:47
06/01/20
06/01
16:47
06/01/20
16:47
PRO

Pros Holdings

$39.90 /

+0.96 (+2.47%)

Baird analyst Rob Oliver…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRO Pros Holdings
$39.90 /

+0.96 (+2.47%)

PRO Pros Holdings
$39.90 /

+0.96 (+2.47%)

05/06/20 Craig-Hallum
Craig-Hallum downgrades Pros Holdings to Hold, cuts target to $35
05/06/20 KeyBanc
Pros Holdings price target raised to $38 from $33 at KeyBanc
05/06/20 Craig-Hallum
Pros Holdings downgraded to Hold from Buy at Craig-Hallum
05/06/20 RBC Capital
Pros Holdings price target lowered to $40 from $75 at RBC Capital
PRO Pros Holdings
$39.90 /

+0.96 (+2.47%)

Initiation
Sprout Social initiated with an Outperform at Baird » 16:46
06/01/20
06/01
16:46
06/01/20
16:46
SPT

Sprout Social

$29.22 /

+1.57 (+5.68%)

Baird analyst Rob Oliver…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPT Sprout Social
$29.22 /

+1.57 (+5.68%)

SPT Sprout Social
$29.22 /

+1.57 (+5.68%)

02/27/20 KeyBanc
Sprout Social price target raised to $27 from $22 at KeyBanc
01/07/20 Morgan Stanley
Sprout Social initiated with an Overweight at Morgan Stanley
01/07/20 KeyBanc
Sprout Social initiated with an Overweight at KeyBanc
01/07/20 Goldman Sachs
Sprout Social initiated with a Buy at Goldman Sachs
SPT Sprout Social
$29.22 /

+1.57 (+5.68%)

SPT Sprout Social
$29.22 /

+1.57 (+5.68%)

Syndicate
9 Meters Biopharma files to sell 84.6M shares of common stock for holders  16:46
06/01/20
06/01
16:46
06/01/20
16:46
NMTR

9 Meters Biopharma

$0.57 /

+0.0258 (+4.72%)

 
ShowHide Related Items >><<
NMTR 9 Meters Biopharma
$0.57 /

+0.0258 (+4.72%)

NMTR 9 Meters Biopharma
$0.57 /

+0.0258 (+4.72%)

Syndicate
Guardant Health announces offering of 10M shares of common stock » 16:45
06/01/20
06/01
16:45
06/01/20
16:45
GH

Guardant Health

$88.19 /

-2.22 (-2.46%)

Guardant Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$88.19 /

-2.22 (-2.46%)

GH Guardant Health
$88.19 /

-2.22 (-2.46%)

05/08/20 Citi
Guardant Health price target raised to $110 from $100 at Citi
04/23/20 SVB Leerink
Guardant Health price target lowered to $125 from $130 at SVB Leerink
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
02/21/20
Fly Intel: Top five analyst initiations
GH Guardant Health
$88.19 /

-2.22 (-2.46%)

GH Guardant Health
$88.19 /

-2.22 (-2.46%)

General news
Treasury Market Summary » 16:45
06/01/20
06/01
16:45
06/01/20
16:45

Treasury Market Summary:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Visa reports May total U.S. payments volume down 5% y/y » 16:43
06/01/20
06/01
16:43
06/01/20
16:43
V

Visa

$194.45 /

-0.68 (-0.35%)

According to a regulatory…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
V Visa
$194.45 /

-0.68 (-0.35%)

V Visa
$194.45 /

-0.68 (-0.35%)

08:29 Today Wedbush
Visa price target raised to $220 from $200 at Wedbush
05/20/20 Cowen
Visa price target raised to $196 from $189 at Cowen
05/06/20 Stephens
Visa franchises will exit recession stronger, says Stephens
05/04/20 BMO Capital
Visa price target lowered to $213 from $234 at BMO Capital
V Visa
$194.45 /

-0.68 (-0.35%)

V Visa
$194.45 /

-0.68 (-0.35%)

V Visa
$194.45 /

-0.68 (-0.35%)

V Visa
$194.45 /

-0.68 (-0.35%)

Conference/Events
MyoKardia participates in a conference call with Cantor Fitzgerald » 16:41
06/01/20
06/01
16:41
06/01/20
16:41
MYOK

MyoKardia

$103.03 /

+0.61 (+0.60%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYOK MyoKardia
$103.03 /

+0.61 (+0.60%)

MYOK MyoKardia
$103.03 /

+0.61 (+0.60%)

05/20/20 Cantor Fitzgerald
MyoKardia price target raised to $188 from $95 at Cantor Fitzgerald
05/14/20 BMO Capital
MyoKardia price target raised to $148 from $90 at BMO Capital
05/12/20 Citi
MyoKardia takeout value in $160 to $190 per share range, says Citi
05/11/20 Cowen
MyoKardia price target raised to $145 from $104 at Cowen
MYOK MyoKardia
$103.03 /

+0.61 (+0.60%)

MYOK MyoKardia
$103.03 /

+0.61 (+0.60%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.